Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2803)
All Articles published online
|
Jan 1, 2004 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Szalay F, Hantos MB, Horvath A, Lakatos PL, Folhoffer A, Dunkel K, Hegedus D, Tekes K. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World J Gastroenterol 2004; 10(1): 42-45 [PMID: 14695766 DOI: 10.3748/wjg.v10.i1.42] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i1/42.htm |
| Number | Citing Articles |
| 1 |
David E. Kaminsky, Thomas J. Rogers. Suppression of CCL2/MCP-1 and CCL5/RANTES Expression by Nociceptin in Human Monocytes. Journal of Neuroimmune Pharmacology 2008; 3(2): 75 doi: 10.1007/s11481-007-9086-y
|
| 2 |
Kaiyuan Wang, Yu Zheng, Yinli Yang, Jian Wang, Baihui Li, Feng Wei, Hongwei Zhao, Xiubao Ren. Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00235
|
| 3 |
Federico Sireci, Francesco Lorusso, Francesco Dispenza, Angelo Immordino, Salvatore Gallina, Pietro Salvago, Francesco Martines, Giuseppe Bonaventura, Maria Laura Uzzo, Giovanni Francesco Spatola. A Prospective Observational Study on the Role of Immunohistochemical Expression of Orphanin in Laryngeal Squamous Cell Carcinoma Recurrence. Journal of Personalized Medicine 2023; 13(8): 1211 doi: 10.3390/jpm13081211
|
| 4 |
Saeed Tariq, Syed M. Nurulain, Kornélia Tekes, Ernest Adeghate. Deciphering intracellular localization and physiological role of nociceptin and nocistatin. Peptides 2013; 43: 174 doi: 10.1016/j.peptides.2013.02.010
|
| 5 |
Xiaoqiang Wang, Yiying Tao, Chaojin Zhang, Jie Tian, Weifeng Yu. Expression heterogeneity, tumor immune characteristics and the prognosis effects of OPRL1 in patients with tumors: a pan-cancer study combined with bioinformation analyses and in vitro validation. Anesthesiology and Perioperative Science 2024; 2(1) doi: 10.1007/s44254-023-00049-9
|
| 6 |
T.A. Barnes, D.G. Lambert. Editorial III: Nociceptin/orphanin FQ peptide-receptor system: are we any nearer the clinic?. British Journal of Anaesthesia 2004; 93(5): 626 doi: 10.1093/bja/aeh226
|
| 7 |
Miklós Krepuska, Péter Sótonyi, Csaba Csobay-Novák, Zoltán Szeberin, István Hartyánszky, Endre Zima, Nóra Szilágyi, Ferenc Horkay, Béla Merkely, György Acsády, Kornélia Tekes. Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases—A pilot study. Regulatory Peptides 2011; 169(1-3): 1 doi: 10.1016/j.regpep.2011.01.007
|
| 8 |
Diego M. Avella, Eric T. Kimchi, Renee N. Donahue, Hephzibah Rani S. Tagaram, Patricia J. McLaughlin, Ian S. Zagon, Kevin F. Staveley-O'Carroll. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancer. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2010; 298(2): R459 doi: 10.1152/ajpregu.00646.2009
|
| 9 |
Emilia Naydenova, Petar Todorov, Rositza Zamfirova. Nociceptin Opioid. Vitamins & Hormones 2015; 97: 123 doi: 10.1016/bs.vh.2014.11.005
|
| 10 |
Richard J. Bodnar, Gad E. Klein. Endogenous opiates and behavior: 2004. Peptides 2005; 26(12): 2629 doi: 10.1016/j.peptides.2005.06.010
|
| 11 |
Aldo Spadaro, Antonino Ajello, Carmelo Luigiano, Carmela Morace, Maria Letizia Resta, Grazia Berlinghieri, Salvatore Campo, Claudio Scisca, Angela Alibrandi, Graziella D’arrigo, Nunziata Alessi, Oscar Ferraù, Maria Antonietta Freni. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(29): 4716-4720 doi: 10.3748/wjg.v12.i29.4716
|
| 12 |
Melinda Ligeti, Özge Gündüz, Anna Magyar, Erzsébet Kató, András Z. Rónai, Claudio Vita, Imre Varga, Ferenc Hudecz, Géza Tóth, Anna Borsodi, Sándor Benyhe. Synthesis and biological studies of nociceptin derivatives containing the DTPA chelating group for further labeling with therapeutic radionuclides. Peptides 2005; 26(7): 1159 doi: 10.1016/j.peptides.2005.01.018
|
| 13 |
Kate H. Easten, Rachel A. Harry, Wendy M. Purcell, Julie D. McLeod. Nociceptin-induced modulation of human T cell function. Peptides 2009; 30(5): 926 doi: 10.1016/j.peptides.2009.01.021
|
| 14 |
Benito Anton, Phillipe Leff, Joseph J. Meissler, Juan C. Calva, Rodolfo Acevedo, Alberto Salazar, Maura Matus, Anabel Flores, Martin Martinez, Martin W. Adler, John P. Gaughan, Toby K. Eisenstein. Nociceptin/Orphanin FQ Suppresses Adaptive Immune Responses In Vivo and at Picomolar Levels In Vitro. Journal of Neuroimmune Pharmacology 2010; 5(1): 143 doi: 10.1007/s11481-010-9190-2
|
| 15 |
George Notas, Marilena Kampa, Artemissia-Phoebe Nifli, Kostas Xidakis, Despoina Papasava, Kyriaki Thermos, Elias Kouroumalis, Elias Castanas. The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors. European Journal of Pharmacology 2007; 555(1): 1 doi: 10.1016/j.ejphar.2006.10.018
|
| 16 |
Tessy Joseph, Tat Leang Lee, Chou Ning, Yuji Nishiuchi, Terutoshi Kimura, Hiroyuki Jikuya, Keli Ou, Yau Chin Chin, Shinro Tachibana. Identification of mature nocistatin and nociceptin in human brain and cerebrospinal fluid by mass spectrometry combined with affinity chromatography and HPLC. Peptides 2006; 27(1): 122 doi: 10.1016/j.peptides.2005.06.013
|
| 17 |
K.M Standifer, C. Simpson-Durand. Reference Module in Biomedical Sciences. 2016; doi: 10.1016/B978-0-12-801238-3.99357-7
|
| 18 |
Lubomir Petrov, Elina Tzvetanova, Almira Pavlova, Albena Alexandrova, Rositsa Zamfirova, Margarita Kirkova, Simeon Todorov. In-vivo effects of nociceptin and its structural analogue [Orn9] nociceptin on the antioxidant status of rat blood and liver after carrageenan-induced paw inflammation. Open Medicine 2010; 5(1): 123 doi: 10.2478/s11536-009-0117-3
|